Global Generic Drugs Market Analysis and Forecast to 2021

PUNE, India, October 27, 2016 /PRNewswire/ --

ReportsnReports.com adds new market research titled "The Future of Generic Drugs and Strategies for Commercial Success" to its store, discussing trends in the global generic drugs market, and the evolving business strategies being adopted and leveraged by generic drug companies around the world. This research conducted an extensive and targeted industry survey of experts from top global generic drug companies, to gather opinions on the trends and future commercial prospects of the generic drugs market. The findings from the survey and results from extensive data analysis and secondary research efforts have been triangulated to provide an objective assessment that is comprehensive in outlook.

Top Global Generic Drug Companies discussed in this research are Teva, Sandoz, Mylan, Sun Pharma, Aspen, Hospira, Fresenius Kabi and Lupin. Complete report on Generic Drugs market with 14 market data tables and 45 figures, spread across 83 pages is available at http://www.reportsnreports.com/reports/725322-the-future-of-generic-drugs-and-strategies-for-commercial-success.html.

The generic drugs market has seen rapid expansion for more than 30 years, and consistently achieves higher annual growth rates than the overall pharmaceutical market. The increase in generic drug activity can be primarily attributed to the promise of significant revenues from blockbuster drugs nearing patent expiry. In the US - the largest generic drugs market by revenue - the number of generic drug approvals hit a record high in 2015, due to a new program that aimed to speed up approvals. There has also recently been a surge in the number of industry-transforming mergers and acquisitions, with companies looking to consolidate their position in this highly lucrative market.

The report covers key small molecule drugs whose patents will expire in the coming years, providing an in-depth assessment of potential generic competition, expected launch dates and the overall impact on global branded revenues to 2021. The top global generic drug companies by revenue are also examined, including financial performance and recent activity within the market.

This new report adds to our unique portfolio of trusted industry analyses, which enable our clients to assess the most promising commercial areas in the market and identify key business opportunities.

Order a copy of this report @ http://www.reportsnreports.com/purchase.aspx?name=725322.

Scope of this research report: What is the current value of the generic drugs market, and how will market dynamics change in the coming years? Will the US continue to dominate the market? Which therapy areas will witness the highest level of genericization in the next five years?